More than 21 lakh mRNA have been removed from CDL Kasauli. doses of COVID-19 vaccine

0
1
 More than 21 lakh mRNA have been removed from CDL Kasauli.  doses of COVID-19 vaccine

Gennova’s mRNA vaccine is an Omicron-specific vaccine and has already tweaked its mRNA platform that will target Omicron. ANI went further and generated some more queries to the company about the latest updates on data submitted to CDSCO but the company refused to answer.

Story Highlights

  • The company hasn’t submitted the data of phase 3 trials to the Central Drug Standard Control Organisation (CDSCO) yet, but interim data for the approval has been submitted by the company in the month of March. The company said that it has filed its phase 2 data with CDSCO in the month of January this year.